Schedule 13G ownership disclosure
Jade Biosciences Inc
Common Stock · CUSIP: 008064206
Event date: 2025-12-31
- Filing-level shares
- 2,095,767
- Percent of class
- 4.24%
- The Vanguard Group
Shares: 2,095,767 · Class: 4.24%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000167
- Form type
- SCHEDULE 13G/A
- Filer
- Jade Biosciences, Inc.
- CIK
- CIK 1798749
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership